je.st
news
FDA panel backs Novo Nordisk injection for obesity
2014-09-12 00:55:12| Biotech - Topix.net
Federal health experts say Novo Nordisk's diabetes drug Victoza should be approved for a new use in treating obesity. The panel of Food and Drug Administration advisers voted 14-1 that the injectable drug's benefits outweigh its risks for patients who are obese or dangerously overweight.
Tags: panel
novo
injection
backs
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||